Sign Out
Pletaal is indicated for the improvement of the maximal and pain-free walking distances in patients with intermittent claudication, who do not have rest pain and who do not have evidence of peripheral tissue necrosis.
Pletaal is indicated for prevention of recurrence of cerebral infarction (excluding cardiogenic cerebral embolism). The effects of PLETAAL on cerebral infarction have not been studied in patients with asymptomatic cerebral infarction.
